NM_000384.3(APOB):c.9811G>A (p.Gly3271Ser) AND Cardiovascular phenotype

Germline classification:: Likely benign (1 submission)
Last evaluated:: Sep 2, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002374567.9

Allele description [Variation Report for NM_000384.3(APOB):c.9811G>A (p.Gly3271Ser)]

NM_000384.3(APOB):c.9811G>A (p.Gly3271Ser)

Gene:

APOB:apolipoprotein B [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2p24.1

Genomic location:

Preferred name:

NM_000384.3(APOB):c.9811G>A (p.Gly3271Ser)

HGVS:

NC_000002.12:g.21007057C>T
NG_011793.1:g.42017G>A
NM_000384.3:c.9811G>AMANE SELECT
NP_000375.3:p.Gly3271Ser
NC_000002.11:g.21229929C>T
NM_000384.2:c.9811G>A
NP_000375.2:p.G3271S

Protein change:

G3271S

Links:

dbSNP: rs142422341

NCBI 1000 Genomes Browser:

rs142422341

Molecular consequence:

NM_000384.3:c.9811G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Cardiovascular phenotype
Identifiers:: MedGen: CN230736

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002691982	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Likely benign (Sep 2, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID] Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002691982

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Likely benign
(Sep 2, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Pooled DNA resequencing of 68 myocardial infarction candidate genes in French canadians.

Beaudoin M, Lo KS, N'Diaye A, Rivas MA, Dubé MP, Laplante N, Phillips MS, Rioux JD, Tardif JC, Lettre G.

Circ Cardiovasc Genet. 2012 Oct 1;5(5):547-54. doi: 10.1161/CIRCGENETICS.112.963165. Epub 2012 Aug 25.

PubMed [citation]

PMID:: 22923420

Details of each submission

From Ambry Genetics, SCV002691982.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 8, 2024

ClinVar

Relating variation to medicine